SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001387131-22-001682
Filing Date
2022-02-11
Accepted
2022-02-11 16:13:15
Documents
1
Group Members
DAVID BONDERMANJAMES G. COULTERJON WINKELRIED

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13G satsuma-sc13ga_011222.htm SC 13G/A 118136
  Complete submission text file 0001387131-22-001682.txt   119790
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Subject) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91126 | Film No.: 22621031
SIC: 2834 Pharmaceutical Preparations

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102 (817) 871-4000
TPG GP A, LLC (Filed by) CIK: 0001903793 (see all company filings)

IRS No.: 872054646 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A